Hydrochloric Acid → C-[6-(2,4-Dichloro-phenyl)-8-methoxy-3-morpholin-4-yl-imidazo[1,2-a]pyridin-7yl]-methylamine
Reaction equation
Cl[C:2]1[C:3]2[N:4]([C:18]([N:21]3[CH2:26][CH2:25][O:24][CH2:23][CH2:22]3)=[CH:19][N:20]=2)[CH:5]=[C:6]([C:10]2[CH:15]=[CH:14][C:13]([Cl:16])=[CH:12][C:11]=2[Cl:17])[C:7]=1[C:8]#[N:9].C[O-].[Na+].B.C1C[O:34][CH2:33]C1.Cl>CO.O1CCOCC1.O>[Cl:17][C:11]1[CH:12]=[C:13]([Cl:16])[CH:14]=[CH:15][C:10]=1[C:6]1[C:7]([CH2:8][NH2:9])=[C:2]([O:34][CH3:33])[C:3]2[N:4]([C:18]([N:21]3[CH2:26][CH2:25][O:24][CH2:23][CH2:22]3)=[CH:19][N:20]=2)[CH:5]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 3
Procedure
A mixture of 8-chloro-6-(2,4-dichloro-phenyl)-3-morpholin-4-yl-imidazo[1,2-a]pyridine-7-carbonitrile (20 mg, 0.05 mmol, prepared according to Example 30, Step 16.1) and NaOMe (8.2 mg, 0.15 mmol) in MeOH (0.5 mL) was refluxed and stirred for 1 h. The reaction mixture was cooled to RT, poured into water (20 ml) and extracted with DCM (3×10 mL). The combined organic fractions were dried over Na2SO4, filtered, and evaporated. The remaining residue was dissolved in THF and a BH3.THF complex (1.0 M solution in THF, 0.2 mL, 0.2 mmol) followed by a 4M HCl solution in dioxane (2 drops) were added. The reaction mixture was stirred and refluxed for 2 h30, then cooled to 0° C. (ice bath) and poured into MeOH. The resulting solution was evaporated to dryness and the remaining residue was purified by reverse phase prep-HPLC (Waters system) to give the title compound (2TFA salt, 3.3 mg, 0.005 mmol, 9% for 2 steps). MS: 407 [M+1]+; HPLC: AtRet=1.09.
Workup
- temperaturewas refluxed
- extractionextracted with DCM (3×10 mL)
- dry with materialThe combined organic fractions were dried over Na2SO4
- filtrationfiltered
- customevaporated
- dissolutionThe remaining residue was dissolved in THF
- additionwere added
- stirringThe reaction mixture was stirred
- temperaturerefluxed for 2 h30
- temperaturecooled to 0° C. (ice bath)
- customThe resulting solution was evaporated to dryness
- customthe remaining residue was purified by reverse phase prep-HPLC (Waters system)
Sources & evidence
- ORD record
- ord-cf097293f0584f62a1e7f1d2be41f0dd
- Source dataset
- uspto-grants-2012_01
- Patent number
- US08097617B2
Reaction notes
Loading…